Reactive hypoglycemia Nutritional, Metabolic, Endocrine
Conditions
Interventions
The subjects enrolled in the study are randomized and consequently divided into two homogeneous groups to receive the two dietary treatments in opposite sequence. Over a period of 6 days they are lodg
Sponsors
UPM Un Punto Macrobiotico International Association (Italy)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Non-diabetic patients 2. Both sexes 3. Aged at least 18 years old 4. BMI between 18 and 35 kg/m2 5. Able to provide written informed consent and to follow the procedures of the protocol 6. Previous diagnosis of RH, though it was confirmed by MMT before the enrolment
Exclusion criteria
Exclusion criteria: 1. Impaired fasting glucose/impaired glucose tolerance/diabetic patients 2. Subjects affected by insulinoma or by other hypoglycemic endocrine conditions 3. Patients affected by any neoplasia 4. Patients affected by any food behavior disorders 5. Pregnant women 6. Symptoms of hypocalcemia 7. Known or suspected hypersensitivity to any of the ingredients of the administered diets 8. Patients under vitamin K antagonists or corticosteroid treatment 9. Subjects under any drugs therapy which might interfere with glucose metabolism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of the number of episodes of reactive hypoglycemia (blood glucose level below 70 mg/dL) in patients affected by such condition during macrobiotic Ma-Pi 2 diet administration compared to a same period during the administration of a low-GI diet. | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycemic distributions assessment through different readings ( 180 mg/dL), measured and compared between the two dietary treatments | — |
Countries
Italy
Outcome results
None listed